IE831740L - Antitumor antibiotic. - Google Patents

Antitumor antibiotic.

Info

Publication number
IE831740L
IE831740L IE831740A IE174083A IE831740L IE 831740 L IE831740 L IE 831740L IE 831740 A IE831740 A IE 831740A IE 174083 A IE174083 A IE 174083A IE 831740 L IE831740 L IE 831740L
Authority
IE
Ireland
Prior art keywords
antitumor antibiotic
bbm
inhibits
bacteria
gb2124234a
Prior art date
Application number
IE831740A
Other versions
IE55800B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE831740L publication Critical patent/IE831740L/en
Publication of IE55800B1 publication Critical patent/IE55800B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/825—Actinomadura

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A polypeptide antitumor antibiotic designated herein as BBM- 1644 is produced by fermentation of Actinomadura sp. strain H710-49 (ATCC 39144). BBM-1644 inhibits gram-positive and acid-fast bacteria, induces prophage in lysogenic bacteria and inhibits the growth of tumors such as P388 leukemia in mice. [GB2124234A]
IE1740/83A 1982-07-26 1983-07-25 Antitumor antibiotic IE55800B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40146882A 1982-07-26 1982-07-26

Publications (2)

Publication Number Publication Date
IE831740L true IE831740L (en) 1984-01-26
IE55800B1 IE55800B1 (en) 1991-01-16

Family

ID=23587892

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1740/83A IE55800B1 (en) 1982-07-26 1983-07-25 Antitumor antibiotic

Country Status (29)

Country Link
JP (1) JPS5948084A (en)
KR (1) KR840005484A (en)
AU (1) AU567105B2 (en)
BE (1) BE897381A (en)
CA (1) CA1215337A (en)
CH (1) CH657778A5 (en)
CS (1) CS251077B2 (en)
DD (1) DD210075A5 (en)
DE (1) DE3326917A1 (en)
DK (1) DK339683A (en)
ES (1) ES524405A0 (en)
FI (1) FI832676L (en)
FR (1) FR2530663A1 (en)
GB (1) GB2124234B (en)
GR (1) GR78648B (en)
HU (1) HU192165B (en)
IE (1) IE55800B1 (en)
IL (1) IL69313A0 (en)
IT (1) IT1163847B (en)
LU (1) LU84930A1 (en)
MY (1) MY8800125A (en)
NL (1) NL8302610A (en)
NO (1) NO832689L (en)
NZ (1) NZ204965A (en)
OA (1) OA07503A (en)
PT (1) PT77091B (en)
SE (1) SE8304132L (en)
YU (1) YU158583A (en)
ZA (1) ZA835337B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPS606194A (en) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd Novel antibiotic substance sf-2288 and its preparation
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
US5304373A (en) * 1991-10-22 1994-04-19 Bristol-Myers Squibb Co. Antitumor antibiotic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148882A (en) * 1977-06-24 1979-04-10 Pfizer Inc. Polycyclic ether antibiotics produced by new species of actinomycete
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
CA1198386A (en) * 1981-10-22 1985-12-24 Donald B. Borders ANTIBACTERIAL AGENTS LL-C23024.beta. AND IOTA AND MICROORGANISM ACTINOMADURA YUMAENSE NRRL 12515
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora

Also Published As

Publication number Publication date
NL8302610A (en) 1984-02-16
DE3326917A1 (en) 1984-02-02
IT1163847B (en) 1987-04-08
OA07503A (en) 1985-03-31
KR840005484A (en) 1984-11-14
MY8800125A (en) 1988-12-31
DK339683A (en) 1984-01-27
IT8322219A0 (en) 1983-07-25
FI832676A7 (en) 1984-01-27
GR78648B (en) 1984-09-27
IE55800B1 (en) 1991-01-16
GB2124234B (en) 1986-04-03
JPH0526799B2 (en) 1993-04-19
SE8304132D0 (en) 1983-07-25
DD210075A5 (en) 1984-05-30
ES8502161A1 (en) 1984-12-16
SE8304132L (en) 1984-01-27
HUT37167A (en) 1985-11-28
PT77091B (en) 1986-06-26
PT77091A (en) 1983-08-01
ES524405A0 (en) 1984-12-16
HU192165B (en) 1987-05-28
AU567105B2 (en) 1987-11-12
CH657778A5 (en) 1986-09-30
AU1720083A (en) 1984-02-02
FI832676L (en) 1984-01-27
NZ204965A (en) 1986-09-10
YU158583A (en) 1985-12-31
NO832689L (en) 1984-01-27
LU84930A1 (en) 1984-03-22
ZA835337B (en) 1984-03-28
CS251077B2 (en) 1987-06-11
GB8320026D0 (en) 1983-08-24
FR2530663A1 (en) 1984-01-27
GB2124234A (en) 1984-02-15
JPS5948084A (en) 1984-03-19
IL69313A0 (en) 1983-11-30
DK339683D0 (en) 1983-07-25
CA1215337A (en) 1986-12-16
FI832676A0 (en) 1983-07-22
BE897381A (en) 1984-01-26

Similar Documents

Publication Publication Date Title
IE44090L (en) Antibiotic
AU599308B2 (en) Antibiotic A40926 complex and its pure factors PA, PB, A, B and BO
DE3378059D1 (en) Antitumor antibiotics
HUT46338A (en) Process for the isolation of glycopeptides
IE55800B1 (en) Antitumor antibiotic
IE782078L (en) Deoxynarasin antibiotics
AU589918B2 (en) Antitumor antibiotics (LL-E33288 complex)
AU4979085A (en) Cl-1577d, 1557e antibiotic/antitumor compounds
EP0350623A3 (en) Bu-3420t antitumor antibiotic
ES8609485A1 (en) Antitumor antibiotic compound
ES8700316A1 (en) Cl-1724 antibiotic-antitumour compounds, pharmaceutical compositions comprising the compounds and a novel microorganism for producing the compounds.
IE841200L (en) B.b.m. - 1675 antibiotics
YU28089A (en) New acidic polycyclical etheric antibiotic
IE821067L (en) Narasin
MY129978A (en) New antitumor antibiotic
ES459663A1 (en) Viridogrisein antibiotics
PL275509A1 (en) Microbiologic method of manufacture of antibiotic uk-61.689 and microorganisms creating that antibiotic
AU562464B2 (en) Macrolide ptl-448-a,b,c and d
AU551023B2 (en) Microorganism and antibiotic therefrom
GR3006381T3 (en)
EP0261936A3 (en) Process for producing glycopeptide antibiotic
IE32578L (en) Preparation of daunorubicin
CA2027629A1 (en) Glycopeptide antibiotics
BG49227A1 (en) Method for preparing antibacterial antibiotic
EP0137692A3 (en) New antibiotic, neocopiamycin a and the production thereof